{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:52Z","timestamp":1788754132875,"version":"build-2803163510"},"reference-count":20,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GSK study identifier","award":["VxHO-000048"],"award-info":[{"award-number":["VxHO-000048"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/21645515.2023.2165382","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T09:53:09Z","timestamp":1675072389000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":7,"title":["Meningococcal serogroup B vaccination series initiation in the United States: A real-world claims data analysis"],"prefix":"10.1080","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4731-6956","authenticated-orcid":false,"given":"Elizabeth R.","family":"Packnett","sequence":"first","affiliation":[{"name":"Merative (formerly IBM Watson Health)","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5819-7844","authenticated-orcid":false,"given":"Nicole M.","family":"Zimmerman","sequence":"additional","affiliation":[{"name":"Merative (formerly IBM Watson Health)","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0655-4672","authenticated-orcid":false,"given":"Patricia","family":"Novy","sequence":"additional","affiliation":[{"name":"GSK","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-9746","authenticated-orcid":false,"given":"Laura C.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Merative (formerly IBM Watson Health)","place":["Cambridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7380-2114","authenticated-orcid":false,"given":"Nnenna","family":"Chime","sequence":"additional","affiliation":[{"name":"GSK","place":["Rockville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-5590","authenticated-orcid":false,"given":"Parinaz","family":"Ghaswalla","sequence":"additional","affiliation":[{"name":"GSK","place":["Philadelphia, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-61779-346-2_2"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.04.020"},{"key":"e_1_3_6_4_1","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal disease. Surveillance. Atlanta (GA): National Center for Immunization and Respiratory Diseases; 2022 Feb 7. [accessed 2022 Mar 2]. https:\/\/www.cdc.gov\/meningococcal\/surveillance\/index.html."},{"key":"e_1_3_6_5_1","unstructured":"Centers for Disease Control and Prevention (CDC). Enhanced meningococcal disease surveillance report. Atlanta (GA): National Center for Immunization and Respiratory Diseases; 2019. [accessed 2021 Dec 15]. https:\/\/www.cdc.gov\/meningococcal\/downloads\/NCIRD-EMS-Report-2019.pdf."},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6441a3"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6619a6"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6909a1"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6733a1"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6833a2"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6933a1"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7035a1"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7135a1"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000003455"},{"key":"e_1_3_6_15_1","unstructured":"Immunization Action Coalition. State laws and mandates by vaccine. Minnestota (MN): Immunization Action Coalition; 2021 May 24. [accessed 2021 Nov 26]. https:\/\/www.immunize.org\/laws\/."},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1712934"},{"key":"e_1_3_6_17_1","unstructured":"Centers for Disease Control and Prevention (CDC). Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2021. Atlanta (GA): National Center for Immunization and Respiratory Diseases; 2022 Feb 17. [accessed 2022 Oct 5]. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/child-adolescent.html."},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2021.04.029"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.06.065"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.03.071"},{"key":"e_1_3_6_21_1","unstructured":"Centers for Disease Control and Prevention (CDC). Vaccines for Children Program (VFC). Atlanta (GA): National Center for Immunization and Respiratory Diseases; 2016 Feb 18. [accessed 2021 Jun 17]. https:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/index.html."}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2023.2165382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T18:24:39Z","timestamp":1746815079000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2023.2165382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/21645515.2023.2165382"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2023.2165382","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-16","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2165382"}}